Gates Foundation Invests $120 Mn For Covid Pill Access
Mohammad Ali (@ChaudhryMAli88) Published October 20, 2021 | 09:30 AM
Washington, (UrduPoint / Pakistan Point News - 20th Oct, 2021 ) :The Bill and Melinda Gates Foundation on Wednesday announced an investment of up to $120 million in an effort to speed up low-income countries' access to a new anti-Covid drug.
The treatment, a pill called molnupiravir developed by US lab Merck, reduces the risk of hospitalization by half in Covid-19 patients who take it in their first few days of infection, the company has said, and could be even more effective at preventing deaths from the virus.
The money from the Gates Foundation would be used to encourage the production of generic forms of the drug by other companies, especially in India, to which Merck has already granted such licenses.
"This commitment builds on the foundation's ongoing efforts... to increase access to Covid-19 vaccines, treatments and tests by supporting R&D, regulatory work, at-risk manufacturing and product delivery," the foundation said in a statement Wednesday.
The drug, which as a tablet is easier to administer than other existing intravenous treatment options, could offer another important pandemic-fighting opportunity for countries that are still struggling to access enough vaccines for their populations.
The food and Drug Administration (FDA) is currently reviewing the medication for approval in the United States.
Merck has predicted it will be able to produce enough doses to make 10 million courses of treatment by the end of the year.
But the roll-out risks following the same trajectory as the anti-Covid vaccines, going almost entirely to rich countries first, with low-income countries left scrambling.
"The global supply (of vaccines) was bought up in wealthier countries," Trevor Mundel, president of the Global Health Division at the Gates Foundation, told AFP.
Getting other companies to produce generics could mean there will be more doses to go around, he said.
"Some of them have said 'We can easily do 10 million courses a month if we get up to our high capacity,'" Mundel said.
"But the problem is that they probably won't do that until they see what the demand is and who will be paying for this. So that's what we want to accelerate, we want them to not wait" to start production.
And the Gates Foundation has already helped some of those companies "have a way to make the drug which is much simpler and much more cost effective. And we've given that technology to the generics manufacturers," Mundel said.
The foundation will also fund a communications campaign around the drug, so that it is well-known and will be used appropriately in the countries where it will be distributed.
Related Topics
Recent Stories
Justice Ishtiaq Ibrahim takes oath as PHC Chief Justice
Mohammad Rizwan likely to be made vice-captain of T20I team
Realme C53 Price Slash: High-Tech Meets High Style at New Low Price!
CPEC has given new boost to economic, cultural relations b/w Pakistan, China: PM
Imran Khan's wife Bushra Bibi's medical tests conducted on court orders
Pakistan requesting multi-billion-dollar loan programme from IMF: Finance Minist ..
Passing out parade of cadets at PMA Kakul
Govt bringing reforms in energy, revenue collection, SOEs: Aurangzeb
Pakistan, New Zealand to face off in 2nd T20I match at Rawalpindi today
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 20 April 2024
Today Gold Rate in Pakistan 20 April 2024
Tennis: ATP Barcelona Open results - 1st update
More Stories From Miscellaneous
-
Transforming education sector: from job hunters to job creators
1 day ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
5 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
6 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
6 days ago -
Radio Bahawalpur presents program “Eidi Shidi”
9 days ago -
Radio Bahawalpur to broadcast Eid programs
11 days ago
-
DC, DPO Haripur inspect bus terminals to review fares compliance
13 days ago -
Second phase of refugees’ repatriation to start after Eidul Fitr vacations
13 days ago -
Reaping bounties as Ramazan culminates
13 days ago -
Digital transformation – a boon or bane
13 days ago -
Plants’ business: Another casualty of climate change
15 days ago -
Eid shoppers prioritize children’s joy over personal comforts
15 days ago